All In Biotech

Free tool

FAERS Monitor: Depakote Er

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020782 or its brand name (Depakote Er, Divalproex Sodium). Reports on generic versions are filed under their own applications.

Reports

46,653

Serious

31,288

67% of reports

Hospitalization

15,214

Death reported

2,596

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,110
  • seizure2,678
  • weight increased2,181
  • nausea2,123
  • off label use2,123
  • fatigue1,981
  • somnolence1,922
  • pain1,905
  • tremor1,853
  • fall1,788
  • anxiety1,723
  • vomiting1,654
  • headache1,623
  • depression1,568
  • insomnia1,567

Reports by year received

View as table
YearReports
20041,203
20051,347
20061,267
20071,289
20081,683
20092,925
20102,531
20112,325
20122,288
20131,971
20142,048
20152,701
20162,840
20172,368
20182,214
20192,253
20202,011
20212,122
20222,178
20231,897
20241,867
20251,954
20261,366

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,007,506 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal2,67810.710.323,060
tremorSignal1,8535.14.96,046
weight increasedSignal2,1814.44.25,782
somnolenceSignal1,9224.34.14,928
depressionSignal1,5683.13.02,268
anxietySignal1,7232.72.61,917
insomniaSignal1,5672.72.51,636
fallSignal1,7882.42.31,519
vomiting1,6541.61.5367
pain1,9051.41.3223
nausea2,1231.21.280
headache1,6231.21.140
fatigue1,9811.11.139
off label use2,1231.11.017
drug ineffective3,1101.11.013

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.